119 filings
Page 4 of 6
8-K
qv9ibwizm02lho
23 Jul 21
Other Events
4:04pm
8-K
f6r6v 3nhnq
15 Jul 21
Other Events
5:06pm
8-K
p55yvrhrx0c3mw
28 Jun 21
Regulation FD Disclosure
4:15pm
8-K
i703 z521ihwqbd
11 Jun 21
Other Events
6:21am
8-K
zibum9p7bwvaklv86a
7 Jun 21
Submission of Matters to a Vote of Security Holders
4:34pm
8-K
568suy
6 May 21
X4 Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
8:13am
8-K
ih6lzt6y3vyxks
9 Apr 21
Regulation FD Disclosure
4:09pm
8-K
czst8t 0e
19 Mar 21
X4 Pharmaceuticals Announces $55.0 Million At-the-Market Private Placement Financing
9:05am
8-K
yt8yta2cp4w6d2a
4 Mar 21
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
8:23am
8-K
9el1y
8 Jan 21
Regulation FD Disclosure
4:17pm
8-K
vw2d3lswkzjv
23 Dec 20
Entry into a Material Definitive Agreement
5:01pm
8-K
3viu o4yq
5 Nov 20
X4 Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
8:13am
8-K
bj7e8tq
16 Oct 20
Entry into a Material Definitive Agreement
4:16pm
8-K
ffjn3rkppwcpaj3xv49d
7 Oct 20
Other Events
5:11pm
8-K
quuo38z 4c
1 Oct 20
X4 Pharmaceuticals Expands Board of Directors Through Appointment of Biopharmaceutical Industry Veteran Alison Lawton
8:31am
8-K
2ekmpfncbwnbr5u
11 Sep 20
Other Events
4:26pm
8-K
s8tu46o myml
30 Jul 20
X4 Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update
8:11am
8-K
f9u3qiytm4stk
11 Jun 20
Material Modifications to Rights of Security Holders
4:12pm
8-K
fcbng
7 May 20
X4 Pharmaceuticals Provides Corporate Update, Including Expected Impact of COVID-19, and Reports First Quarter 2020 Financial Results
8:04am
8-K
vzdli
20 Mar 20
Departure of Directors or Certain Officers
4:06pm